器官晶片市場：按產品/服務、應用、最終用戶和地區分類

Organ On A Chip Market, By Products & Service, By Application, By End User, By Geography

出版日期: 2026年04月01日 | 出版商:

Coherent Market Insights | 英文 151 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計到 2026 年，器官晶片市場規模將達到 2.086 億美元，到 2033 年將達到 16.435 億美元。預計從 2026 年到 2033 年，其複合年成長率將達到 34.3%。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	2.086億美元
歷史數據時期：	2020-2024	預測期：	2026-2033
2026年至2033年預測期間的複合年成長率：	34.30%	2033年市場規模預測：	16.435億美元

近年來，受藥物篩檢和毒性測試領域對替代方法的需求不斷成長的推動，全球器官晶片市場呈現顯著成長。器官晶片旨在利用微加工和微流體技術複製人體器官的複雜微環境，從而模擬其生理反應。這些裝置將活細胞整合到配備微通道的晶片上，能夠模擬器官層面的功能和反應。此類裝置被視為開發安全有效藥物的關鍵工具，它不僅經濟高效，還能減少對動物試驗的依賴。隨著技術的進步，預計未來幾年「器官晶片」技術將在各行業中得到更廣泛的應用。

市場動態

全球器官晶片市場的主要驅動力是藥物研發成本飆升和新藥候選藥物成功率低。器官晶片為藥物和化學品測試提供了一個平台，幫助製藥公司降低失敗率並控制研發成本。此外，對藥物安全性和有效性的嚴格監管，以及對動物試驗中「3R」（替代、減少、改進）原則日益重視，都對器官晶片技術的應用產生了積極影響。然而，器官晶片設備的高成本以及缺乏標準化的測試結果檢驗程序阻礙了市場成長。另一方面，私人和政府機構對器官晶片研究投入的不斷增加，為市場相關人員創造了新的機會。

本研究的關鍵特徵

本研究確定了各個細分市場的潛在商機，並說明了該市場具有吸引力的投資提案矩陣。
此外，本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
本研究根據以下參數分析了全球器官晶片市場的主要參與企業：公司亮點、產品系列、關鍵亮點、財務表現和策略。
透過利用本報告中的見解，企業行銷負責人和經營團隊可以就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
全球器官晶片市場報告的目標受群眾外包括該行業的各類相關人員，例如投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
相關人員可以利用全球晶片器官市場分析中使用的各種策略矩陣輕鬆做出決策。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 阿根廷
- 墨西哥
- 其他拉丁美洲國家
歐洲
- 德國
- 英國
- 西班牙
- 法國
- 義大利
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- 澳洲
- 韓國
- ASEAN
- 其他亞太國家
中東
- GCC
- 以色列
- 其他中東國家
非洲
- 南非
- 北非
- 中非

第8章競爭情勢

Emulate, Inc.
Mimetas
Organovo Holdings, Inc.
Roche
AstraZeneca
Pfizer
Harvard Bioscience, Inc.
CN Bio Innovations
AxoSim
Synlogic, Inc.
Alcyomics Ltd.
3D BIoTek
Vascularized Organs, Inc.
InSphero AG
Hesperos Inc
NETRI
Obatala Sciences, Inc.

第9章分析師建議

機會分析
一致的機會地圖

第10章：參考文獻與調查方法

參考
調查方法
關於本公司

簡介目錄

Product Code: CMI49

Organ On A Chip Market is estimated to be valued at USD 208.6 Mn in 2026 and is expected to reach USD 1,643.5 Mn by 2033, growing at a compound annual growth rate (CAGR) of 34.3% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 208.6 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	34.30%	2033 Value Projection:	USD 1,643.5 Mn

The global organ-on-a-chip market has been gaining significant traction in the past few years owing to the growing demand for alternative methods for drug screening and toxicity testing. organ-on-a-chip devices aim to mimic the physiological responses of human organs by replicating their complex microenvironment using microfabrication and microfluidic technologies. They incorporate living cells on a chip lined with microchannels and are capable of modelling organ-level functions and responses. Such devices are being seen as crucial tools for developing safe and effective drugs in a cost-effective manner while reducing dependence on animal testing. With technological advancements, the organ-on-a-chip technology is expected witness wider adoption across various industries in the coming years.

Market Dynamics

The global organ-on-a-chip market is primarily driven by the rising drug development costs and limited success of new drug entities. Organ-on-a-chips provide human-body-on-a-chip platforms for testing drugs and chemical compounds, thus helping drug makers reduce failure rates and curb R&D expenditure. Moreover, stringent regulations regarding safety and efficacy of drugs along with growing emphasis on the 3Rs (Replacement, Reduction, and Refinement) in animal testing is positively influencing the adoption of organ-chip technology. However, the high costs associated with the development of organ-on-a-chip devices and lack of standardized procedures for validation of test results are some of the factors hindering the market growth. Meanwhile, growing funding from private and government bodies for organ chip research is creating new opportunities for market players.

Key Features of the Study

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global organ-on-a-chip market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study include Emulate, Inc., Mimetas, Organovo Holdings, Inc., Roche, AstraZeneca, Pfizer, Harvard Bioscience, Inc., CN Bio Innovations, AxoSim, Synlogic, Inc., Alcyomics Ltd., 3D Biotek, Vascularized Organs, Inc., InSphero AG, Hesperos Inc, NETRI, and Obatala Sciences, Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
The global organ-on-a-chip market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global organ-on-a-chip market.

Market Segmentation

Products & Service Insights (Revenue, USD Mn, 2021 - 2033)
Products
- Instruments
- Devices
  - Heart-on-Chip
  - Lung-on-Chip
  - Liver-on-Chip
  - Kidney-on-Chip
  - Brain-on-Chip
  - Intestine-on-Chip
  - Others
- Services
Application Insights (Revenue, USD Mn, 2021 - 2033)
Toxicology Testing
Disease Modelling/Physiological model development
Drug discovery
Stem cell research
Tissue regeneration and regenerative medicines
End User Insights (Revenue, USD Mn, 2021 - 2033)
Pharmaceutical and Biotechnology Companies
Academic & Research Institutes
Contract Research Organizations
Others
Regional Insights (Revenue, USD Mn, 2021 - 2033)
North America
- U.S.
- Canada
Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- GCC Countries
- Israel
- Rest of Middle East
Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
Emulate, Inc.
Mimetas
Organovo Holdings, Inc.
Roche
AstraZeneca
Pfizer
Harvard Bioscience, Inc.
CN Bio Innovations
AxoSim
Synlogic, Inc.
Alcyomics Ltd.
3D Biotek
Vascularized Organs, Inc.
InSphero AG
Hesperos Inc
NETRI
Obatala Sciences, Inc.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Organ-on-a-Chip Market, By Products & Service
- Global Organ-on-a-Chip Market, By Application
- Global Organ-on-a-Chip Market, By End User
- Global Organ-on-a-Chip Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Driver
- Restraint
- Opportunity
Impact Analysis
Key Developments
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario
Industry Trends

4. Global Organ-on-a-Chip Market, By Products & Service, 2021 - 2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Products
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
  - Instruments
  - Devices
    - Heart-on-Chip
    - Lung-on-Chip
    - Liver-on-Chip
    - Kidney-on-Chip
    - Brain-on-Chip
    - Intestine-on-Chip
    - Others
Services
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)

5. Global Organ-on-a-Chip Market, By Application, 2021 - 2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Toxicology Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
Disease Modelling/Physiological model development
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
Drug discovery
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
Stem cell research
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
Tissue regeneration and regenerative medicines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)

6. Global Organ-on-a-Chip Market, By End User, 2021 - 2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Pharmaceutical and Biotechnology Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
Academic & Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
Contract Research Organizations
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)

7. Global Organ-on-a-Chip Market, By Region, 2021 - 2033, Value (USD Mn)

Introduction
- Market Share (%) Analysis, 2026, 2028 & 2033 Value (USD Mn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2033, Value (USD Mn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Products & Service, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Products & Service, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Products & Service, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Products & Service, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Products & Service, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Products & Service, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Mn)
  - South Africa
  - North Africa
  - Central Africa

8. Competitive Landscape

Emulate, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Mimetas
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Organovo Holdings, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Roche
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
AstraZeneca
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Pfizer
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Harvard Bioscience, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
CN Bio Innovations
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
AxoSim
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Synlogic, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Alcyomics Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
3D Biotek
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Vascularized Organs, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
InSphero AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Hesperos Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
NETRI
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Obatala Sciences, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies